Loading...
The Japan Entry Acceleration Program 2025 (JEAP 2025) offers startups in the regenerative medicine and gene therapy sectors a unique opportunity to accelerate their entry into the Japanese market through comprehensive support, including market insights, expert guidance, and a Demo Day to showcase their innovations to potential partners and investors, all at no cost to participants.